Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study

Bianca Buchignani1,2, Gianpaolo Cicala2,3, Francesca Cumbo4

  • 1Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.

Insights

Early language development in spinal muscular atrophy (SMA) type 1 is impacted, even with treatment. While some skills emerge, they often remain below typical levels, highlighting the need for continued support.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Speech-Language Pathology

Background:

  • Spinal muscular atrophy (SMA) type 1 is a severe genetic disorder affecting motor neurons.
  • Early diagnosis and intervention are crucial for managing SMA type 1.
  • Understanding early language acquisition in treated SMA type 1 is vital for developmental outcomes.

Purpose of the Study:

  • To evaluate early language development in infants with SMA type 1 receiving treatment.
  • To compare language acquisition in treated SMA type 1 infants with those identified via newborn screening (NBS).

Main Methods:

  • Utilized the MacArthur-Bates Communicative Development Inventory (MB-CDI) for parent-reported assessments.
  • Assessed comprehension, gesture, and expressive language skills in 24 treated SMA type 1 and 12 NBS-identified infants (8-36 months).
  • Conducted a follow-up assessment on a subset of participants.

Main Results:

  • Comprehension skills were largely preserved in both groups (81% SMA type 1, 87% NBS).
  • Gesture and lexical expression skills were significantly delayed in SMA type 1 infants (55% and >80% below 5th centile, respectively).
  • Follow-up showed lexical improvements but persistent delays in 43% of SMA type 1 and 86% of NBS-identified infants.

Conclusions:

  • Language development in treated SMA type 1 may parallel motor function, with some skills emerging but not reaching typical peer levels.
  • Treated infants demonstrate some language abilities not seen in untreated peers.
  • Further research and support are needed to optimize communication development in this population.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...